BREAST-CANCER - CHEMOTHERAPY IN THE TREATMENT OF ADVANCED DISEASE

被引:31
作者
CLAVEL, M
CATIMEL, G
机构
[1] Centre Léon Bérard, 69373 Lyon Cedex 08, 28, rue Laennec
关键词
D O I
10.1016/S0959-8049(05)80161-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemotherapy in patients with advanced breast cancer remains palliative. Although the majority of patients will experience an initial response or stabilisation of the disease, the survival is only modestly improved. The search for new drugs and more effective combinations must therefore continue. High-dose chemotherapy with or without autologous bone marrow transplant (ABMT) is an enthusiastic perspective of progress but the available data do not permit conclusions about the effectiveness of high-dose therapy compared with conventional treatment.
引用
收藏
页码:598 / 604
页数:7
相关论文
共 96 条
[61]  
LLUCH A, 1992, P AN M AM SOC CLIN, V11, P72
[62]  
MADSEN EL, 1991, 5TH P BREAST CANC WO
[63]  
MARGOLIN K, 1991, P AM SOC CLIN ONCOL, V10, P59
[64]  
MARTONI A, 1984, CANCER CHEMOTH PHARM, V12, P179
[65]  
MOURIDSEN HT, 1977, CANCER TREAT REP, V61, P47
[66]  
MUSS HB, 1978, CANCER, V42, P2141, DOI 10.1002/1097-0142(197811)42:5<2141::AID-CNCR2820420509>3.0.CO
[67]  
2-3
[68]   A COMPARISON OF MITOXANTRONE AND DOXORUBICIN IN BREAST-CANCER [J].
NEIDHART, JA ;
GOCHNOUR, D ;
ROACH, R ;
HOTH, D ;
YOUNG, D .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) :672-677
[69]  
NEMOTO T, 1978, CANCER, V41, P2073, DOI 10.1002/1097-0142(197806)41:6<2073::AID-CNCR2820410601>3.0.CO
[70]  
2-7